NCT00765414View on ClinicalTrials.gov

Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

April 30, 2006

Study Completion Date

August 31, 2006

Conditions

Pompe Disease Late-OnsetGlycogen Storage Disease Type II GSD II

Interventions

BIOLOGICAL

Myozyme

30 mg/kg qow f and 40 mg/kg qow

Trial Locations (1)

Unknown

University of Texas Health Science Center at San Antonio, San Antonio

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00765414 - Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies. | Biotech Hunter | Biotech Hunter